These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38014339)

  • 1. Microglia Depletion Reduces Human Neuronal APOE4-Driven Pathologies in a Chimeric Alzheimer's Disease Model.
    Rao A; Chen N; Kim MJ; Blumenfeld J; Yip O; Hao Y; Liang Z; Nelson MR; Koutsodendris N; Grone B; Ding L; Yoon SY; Arriola P; Huang Y
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons.
    Najm R; Zalocusky KA; Zilberter M; Yoon SY; Hao Y; Koutsodendris N; Nelson M; Rao A; Taubes A; Jones EA; Huang Y
    Cell Rep; 2020 Jul; 32(4):107962. PubMed ID: 32726626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
    Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
    J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.
    Lin YT; Seo J; Gao F; Feldman HM; Wen HL; Penney J; Cam HP; Gjoneska E; Raja WK; Cheng J; Rueda R; Kritskiy O; Abdurrob F; Peng Z; Milo B; Yu CJ; Elmsaouri S; Dey D; Ko T; Yankner BA; Tsai LH
    Neuron; 2018 Jun; 98(6):1141-1154.e7. PubMed ID: 29861287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity.
    Victor MB; Leary N; Luna X; Meharena HS; Scannail AN; Bozzelli PL; Samaan G; Murdock MH; von Maydell D; Effenberger AH; Cerit O; Wen HL; Liu L; Welch G; Bonner M; Tsai LH
    Cell Stem Cell; 2022 Aug; 29(8):1197-1212.e8. PubMed ID: 35931030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia
    Muth C; Hartmann A; Sepulveda-Falla D; Glatzel M; Krasemann S
    Front Cell Neurosci; 2019; 13():181. PubMed ID: 31130847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
    Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
    Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
    Ophir G; Meilin S; Efrati M; Chapman J; Karussis D; Roses A; Michaelson DM
    Neurobiol Dis; 2003 Feb; 12(1):56-64. PubMed ID: 12609489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.
    Colton CA; Brown CM; Cook D; Needham LK; Xu Q; Czapiga M; Saunders AM; Schmechel DE; Rasheed K; Vitek MP
    Neurobiol Aging; 2002; 23(5):777-85. PubMed ID: 12392781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination.
    Wang N; Wang M; Jeevaratnam S; Rosenberg C; Ikezu TC; Shue F; Doss SV; Alnobani A; Martens YA; Wren M; Asmann YW; Zhang B; Bu G; Liu CC
    Mol Neurodegener; 2022 Nov; 17(1):75. PubMed ID: 36419137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation.
    Nelson MR; Liu P; Agrawal A; Yip O; Blumenfeld J; Traglia M; Kim MJ; Koutsodendris N; Rao A; Grone B; Hao Y; Yoon SY; Xu Q; De Leon S; Choenyi T; Thomas R; Lopera F; Quiroz YT; Arboleda-Velasquez JF; Reiman EM; Mahley RW; Huang Y
    Nat Neurosci; 2023 Dec; 26(12):2104-2121. PubMed ID: 37957317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
    Li Y; Macyczko JR; Liu CC; Bu G
    Neurobiol Aging; 2022 Jul; 115():20-28. PubMed ID: 35453035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
    Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
    Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
    Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing human apolipoprotein E levels attenuates age-dependent Aβ accumulation in mutant human amyloid precursor protein transgenic mice.
    Bien-Ly N; Gillespie AK; Walker D; Yoon SY; Huang Y
    J Neurosci; 2012 Apr; 32(14):4803-11. PubMed ID: 22492035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.